Buprenorphine: a treatment and cause of opioid-induced respiratory depression.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34996591.
- Also identified by DOI 10.1016/j.bja.2021.12.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Buprenorphine is a partial agonist at the mu opioid receptor. Due to its relatively low maximum effect on respiratory depression it is considered by some to be a safe opioid. But it can produce serious respiratory depression, particularly when combined with sedatives such as benzodiazepines.
Medical subject headings
- Buprenorphine
- Respiratory Insufficiency